Clin2
NCT07592429Possibly a fitNot yet recruiting

Immune memory after mpox infection

Mpox (Monkeypox)

Treatments studied

Part of Infections clinical trials.

This study looks at how well your immune system remembers the mpox virus after you've been infected. It may help researchers understand protection against future infections.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You took part in the ANRS0258s-MOSAIC cohort between July 2022 and July 2023.
  • You had a blood sample taken within 8 months of your mpox infection.
  • You are 18 years old or older.
  • You are able to give written consent to participate.
  • For France: you are covered by a social security scheme (not just Aide Médicale d'État).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06652646Enrolling by invitation
Mpox study: biology, outcome, transmission, and spread

This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.

Kamituga
NCT07534267Not yet recruiting
Tracking mpox spread and vaccine effectiveness in West Africa

This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.

Conakry
NCT06840197Not yet recruiting
Diagnosing mpox with a new test

This study is testing a new way to diagnose mpox (formerly monkeypox) using a sample from your skin sores. If you have symptoms that look like mpox, this test might help confirm the diagnosis quickly.

Mbandaka, Equateur
NCT07379580Recruiting· Phase 2
Test of an mRNA vaccine for mpox in Africa

This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.

Kinshasa
NCT06984705Enrolling by invitation
Mpox outbreak study in Equateur Province, DRC

This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.

Mbandaka, Équateur Province
NCT07055867Enrolling by invitation
Mpox outbreak study in Equateur, DR Congo

This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.

Mbandaka, Équateur Province

Hear when a new Mpox (Monkeypox) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.